000 02230cam a2200277zu 4500
001 88973005
003 FRCYB88973005
005 20251020124154.0
006 m o d
007 cr un
008 251020s2019 fr | o|||||0|0|||eng d
020 _a9780128163634
035 _aFRCYB88973005
040 _aFR-PaCSA
_ben
_c
_erda
100 1 _aO Tollefsbol, Trygve
245 0 1 _aTransgenerational Epigenetics
_c['O Tollefsbol, Trygve']
264 1 _bAcademic Press
_c2019
300 _a p.
336 _btxt
_2rdacontent
337 _bc
_2rdamdedia
338 _bc
_2rdacarrier
650 0 _a
700 0 _aO Tollefsbol, Trygve
856 4 0 _2Cyberlibris
_uhttps://international.scholarvox.com/netsen/book/88973005
_qtext/html
_a
520 _aTransgenerational Epigenetics, Second Edition, offers the only up-to-date, comprehensive analysis of the inheritance of epigenetic phenomena between generations with an emphasis on human disease relevance, drug discovery, and next steps in clinical translation. International experts discuss mechanisms of epigenetic inheritance, its expression in animal and plant models, and how human ailments, such as metabolic disorders and cardiovascular disease are influenced by transgenerational epigenetic inheritance. Where evidence is sufficient, epigenetic clinical interventions are proposed that may help prevent or reduce the severity of disease before offspring are born. This edition has been thoroughly revised in each disease area, featuring newly researched actors in epigenetic regulation, including long noncoding RNA in addition to histone modifications and DNA methylation. Therapeutic pathways in treating cancer and extending human longevity are also considered, as are current debates and future directions for research. - Presents a fully-updated and expanded release addressing transgenerational epigenetics, epigenetic mechanisms of gene regulation, and the role of epigenetics in human longevity and cancer - Examines the field from "bench-to-bedside", discussing basic science, disease management, current debates, and next steps in epigenetic research and drug discovery - Features chapter contributions from international experts
999 _c1556545
_d1556545